249 related articles for article (PubMed ID: 10638596)
41. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.
Gitlin N; Julie NL; Spurr CL; Lim KN; Juarbe HM
Ann Intern Med; 1998 Jul; 129(1):36-8. PubMed ID: 9652997
[No Abstract] [Full Text] [Related]
42. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
43. Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success.
Nagasaka S; Abe T; Kawakami A; Kusaka I; Nakamura T; Ishikawa S; Saito T; Ishibashi S
Diabet Med; 2002 Apr; 19(4):347-8. PubMed ID: 11943013
[No Abstract] [Full Text] [Related]
44. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
45. Pulmonary edema associated with troglitazone therapy.
Hirsch IB; Kelly J; Cooper S
Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
[No Abstract] [Full Text] [Related]
46. Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.
Cluxton RJ; Li Z; Heaton PC; Weiss SR; Zuckerman IH; Moomaw CJ; Hsu VD; Rodriguez EM
Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):1-9. PubMed ID: 15546159
[TBL] [Abstract][Full Text] [Related]
47. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
Parker JC
Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
[TBL] [Abstract][Full Text] [Related]
48. Lessons from the glitazones: a story of drug development.
Gale EA
Lancet; 2001 Jun; 357(9271):1870-5. PubMed ID: 11410214
[TBL] [Abstract][Full Text] [Related]
49. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
50. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
Bonkovsky HL; Azar R; Bird S; Szabo G; Banner B
Dig Dis Sci; 2002 Jul; 47(7):1632-7. PubMed ID: 12141828
[TBL] [Abstract][Full Text] [Related]
51. Serious liver injury. Leading reason for drug removals, restrictions.
Meadows M
FDA Consum; 2001; 35(3):8-9. PubMed ID: 11458559
[No Abstract] [Full Text] [Related]
52. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
53. Troglitazone. Is it all over?
Wagenaar LJ; Kuck EM; Hoekstra JB
Neth J Med; 1999 Jul; 55(1):4-12. PubMed ID: 10431549
[TBL] [Abstract][Full Text] [Related]
54. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell SH; Hespenheide EE; Redick JA; Iezzoni JC; Battle EH; Sheppard BL
Am J Gastroenterol; 2001 Feb; 96(2):519-25. PubMed ID: 11232700
[TBL] [Abstract][Full Text] [Related]
55. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications".
South D
J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716
[No Abstract] [Full Text] [Related]
56. Conversion from troglitazone to rosiglitazone.
Bell DS; Ovalle F; Shadmany S
Endocr Pract; 2001; 7(4):326. PubMed ID: 11497487
[No Abstract] [Full Text] [Related]
57. Rezulin (troglitazone) greatly increases cyclosporine metabolism.
Frantz RP; Nguyen TT
J Heart Lung Transplant; 1998 Oct; 17(10):1037-8. PubMed ID: 9811416
[No Abstract] [Full Text] [Related]
58. The thiazolidinediones or "glitazones" a treatment option for type 2 diabetes mellitus.
Brown MN
Med Health R I; 2000 Apr; 83(4):118-20. PubMed ID: 10821014
[TBL] [Abstract][Full Text] [Related]
59. Hepatotoxicity of the thiazolidinediones.
Tolman KG; Chandramouli J
Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
[TBL] [Abstract][Full Text] [Related]
60. [Clinical results of troglitazone (CS-045)].
Iwamoto Y
Nihon Rinsho; 1997 Nov; 55 Suppl():131-6. PubMed ID: 9434456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
